• Home
  • News
    • Pre-Meeting
    • Meeting Coverage
    • Post-Meeting
    • Poster Presenters 2024
    • Archives
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
  • Map & Photos
  • Industry
    • Industry Events
      • Featured Industry Events
      • Innovation Theaters
      • Industry-Supported Symposia
      • Lightning Talks
    • Industry Connections
  • Publications
    • Preview Edition Newspaper
    • Meeting Magazine
  • App & Planner
  • Schedule
  • Resources
    • App & Planner
    • Schedule
  • Follow Us
    • X (Twitter)
    • Facebook
    • LinkedIn
    • YouTube
  • Subscribe
Meeting Home

The official news source of ACR Convergence 2024

Watch On Demand
  • Expanding treatment options means comorbidities matter when selecting RA treatment

    Expanding treatment options means comorbidities matter when selecting RA treatment

    November 8, 2020

    Faculty in How I Treat Difficult RA: Panel Session reviewed difficult-to-treat cases for RA patients with ILD, refractory RA, and RA with liver disease.

  • Panel discusses evolution, future considerations of SLE damage assessment index

    Panel discusses evolution, future considerations of SLE damage assessment index

    November 8, 2020

    Quantifying the severity of SLE damage remains a challenge, and an ACR Convergence 2020 session discussed issues pertaining to the development of an improved strategy.

  • Rheumatologists can lead their patients to reliable information in the digital world

    Rheumatologists can lead their patients to reliable information in the digital world

    November 8, 2020

    As more and more patients with rheumatic diseases turn to the digital world for information and support, rheumatologists and their care teams need to know how to guide their patients toward reputable information and away from potentially harmful outcomes.

  • CCP arthritis remains under the radar, but research could lead to treatment breakthroughs

    CCP arthritis remains under the radar, but research could lead to treatment breakthroughs

    November 8, 2020

    Calcium pyrophosphate (CCP) arthritis was first described more than 50 years ago. Since then, researchers have found that this extremely painful type of arthritis is extraordinarily common but significantly underdiagnosed.

  • Session will examine how modulating the microbiome can affect rheumatoid arthritis

    Session will examine how modulating the microbiome can affect rheumatoid arthritis

    November 8, 2020

    The microbiome presents a tremendous opportunity for understanding disease because it’s able to be manipulated once you find the right way, but there’s still so much unknown about finding the right way to manipulate the microbiome.

  • FDA leaders will address challenges and opportunities in pediatric study designs

    November 8, 2020

    The FDA is employing extrapolation of adult efficacy data in drug development programs in rheumatology conditions that demonstrate a similar disease pathophysiology and clinical presentation, similar co-morbidities, and similar response to therapy in pediatric rheumatology patients to achieve the goal of shortening timelines for pediatric…

  • Studies look at whether preclinical treatment may delay, prevent RA

    Studies look at whether preclinical treatment may delay, prevent RA

    November 8, 2020

    Research continues into finding ways to treat rheumatoid arthritis early enough to delay the onset of symptoms or possibly reverse the course of the disease entirely and keep arthritis from developing.

  • New molecular targets could advance OA treatment

    New molecular targets could advance OA treatment

    November 8, 2020

    Only in the past 15 years or so have people accepted the idea that molecular targeting could lead to disease modification in osteoarthritis, and an ACR Convergence 2020 educational session will cover the latest targets in preclinical models and early phase trials involving both mice…

  • Mothers with rheumatic diseases need more support from healthcare providers

    Mothers with rheumatic diseases need more support from healthcare providers

    November 8, 2020

    The education session Reproductive Health: Meet Women’s Needs features three speakers who not only work with patients with rheumatic disease but are also mothers who live with a rheumatic disease.

  • Kristina Clark, MD, MRCP: Blister fluid and plasma in systemic sclerosis

    Kristina Clark, MD, MRCP: Blister fluid and plasma in systemic sclerosis

    November 8, 2020

    MEET THE POSTER PRESENTER: SSc is a severe rheumatic disease with high mortality from lung and heart disease, and major non-lethal clinical burden, including fibrosis of the skin. Sampling skin gives a unique opportunity to explore local disease mechanisms and better understand pathogenesis.

1 2
Next Page

Upcoming Featured Industry Events

View All

View Archives

  • Select Year
    • 2017
    • 2018
    • 2019
    • 2020
    • 2021
    • 2022
    • 2023

Popular Articles

  • Daltroy Lecture Examines the Psychological Impacts of Living with Rheumatic Disease


  • ARP Distinguished Lecture: Better Understanding of AI Will Enhance Its Utility for Rheumatologists


  • FDA Gives Updates on Newly Approved Agents for Rheumatic Diseases


  • Clinicians Discuss Experience Using Ambient Listening Technology in Clinical Practice


  • Opening Session Keynote Spotlights the Crucial Role of Allyship in Rheumatology



@2024 American College of Rheumatology. All Rights Reserved. Powered by TriStar Event Media, LLC

Privacy Policy